Colorado biotech Enveda reports preliminary results on a drug to help people maintain weight loss after GLP-1 use. Just don't call it exercise in a pill.
“Like climate change, antimicrobial resistance is a global challenge, but its causes and consequences are unevenly distributed,” writes GARDP’s Peter Beyer.
A 29-year-old woman confided her suicidal thoughts to an AI chatbot — not to her therapist, not to her parents, not to her best friend. What can AI learn from her death?
Sanofi, one of the Massachusetts' largest pharmaceutical employers, will lay off more than 200 workers there a year after acquiring Blueprint Medicines.
Eyepoint said patients given its experimental treatment for wet AMD failed to maintain vision with less frequent injections compared to a standard treatment.